TG-46
Modify Date: 2024-07-18 17:58:22
TG-46 structure
|
Common Name | TG-46 | ||
|---|---|---|---|---|
| CAS Number | 936091-15-5 | Molecular Weight | 510.652 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 687.5±65.0 °C at 760 mmHg | |
| Molecular Formula | C26H34N6O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 369.6±34.3 °C | |
Use of TG-46JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1]. |
| Name | N-tert-butyl-3-[[5-methyl-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide |
|---|---|
| Synonym | More Synonyms |
| Description | JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 687.5±65.0 °C at 760 mmHg |
| Molecular Formula | C26H34N6O3S |
| Molecular Weight | 510.652 |
| Flash Point | 369.6±34.3 °C |
| Exact Mass | 510.241302 |
| PSA | 120.09000 |
| LogP | 1.83 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.621 |
| EX-8668 |
| RS0111 |
| 3-[(5-Methyl-2-{[4-(4-morpholinylmethyl)phenyl]amino}-4-pyrimidinyl)amino]-N-(2-methyl-2-propanyl)benzenesulfonamide |
| Benzenesulfonamide,N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino] |
| Benzenesulfonamide, N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]- |
| N-tert-butyl-3-(5-methyl-2-(4-(morpholinomethyl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide |
| TG-46 |